Actualizare: “US Mifepristone Label Update Announcement”

US Food and Drug Administration (FDA) announced a major change to the mifepristone (Mifeprex) label.

Below please find a summary to the label changes, which include: the use of 200 mg mifepristone and 800 mcg misoprostol through 70 days gestation; home administration of misoprostol; and follow-up which does not require an in-clinic visit. Furthermore, the medicine may be prescribed by a healthcare provider, rather than a physician only. Included are also links for further information.

News articles